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discussed in relation to the occurrence and
expression of cross-reacting embryonic anti-
gens associated with the cell surface of these
rat tumours.
B AND T CELLS IN CANINE LYMPHO-
SARCOMA. D. E. ONIoNs, Department of
Clinical Veterinary Medicine, University of
Cambridge.
Canine multicentric lymphosarcoma is a
common spontaneous neoplasm of dogs.
Canine lymphoma cells, like normal canine
lymphocytes, may be divided into two classes,
T and B, based on the spontaneous rosette
formation between canine T cells and human
erythrocytes, and the presence of a receptor
for (human) complement on the surface of B
cells.
The presence of an Fc receptor on canine
lymphocytes appears to be an unreliable
marker for B cells as many complement
receptor lymphocytes (EACL) lack a
detectable Fc receptor for using a rosetting
technique with antibody coated eryth-
rocytes.
SCANNING ELECTRON MICROS-
COPY OF K CELL ACTIVITY ON RED
CELL MONOLAYERS. A. E. WILLIAMS,
Western General Hospital, Edinburgh, J. R.
INGLIS, W. J. Penhale, A. FARMER and W. J.
IRVINE, Department of Therapeutics, Uni-
versity of Edinburgh.
K cell activity against syngeneic cells
(De Landazuriet et al., Cell Immunol. 1974,
14, 193) and defects in K cell activity in
cancer patients (Wisloff et al., Scand. J.
Immunol., 1973, 2, 325) have been demon-
strated. However, the identity of the K cell
is still uncertain and conflicting evidence
supports B lymphocytes, monocytes, macro-
phages and other leucocytes.
We have used the SEM to examine the
interaction between human leucocytes
(separated in Ficoll-Triosil and pre-incubated
on glass) and antibody coated sheep erythro-
cyte monolayers (Kennedy and Axelrad,
Immunology, 1971, 20, 253). Only a small
proportion of the leucocyte suspension
adhered to the monolayer and the non-
adherent cells lacked antibody dependent
cytotoxic activity. Three morphologically
distinct cell types were associated with areas
of lysis in the erythrocyte monolayer within
4 h and correlation with light microscopy
suggested that they were macrophages,
granulocytes and lymphoid cells. Surface
changes in the erythrocytes during contact
with K cells indicate that mechanical factors
may be involved in cell lysis in this system.
THERAPY OF METHYL CHOLAN-
THRENE INDUCED CBA MOUSE TU-
MOURS WITH CORYNEBACTERIUM
PARVUM AND IRRADIATED TU-
MOUR CELLS. R. BOMFORD, Depart-
ment of Experimental Immunobiology,
WellcomeResearchLaboratories,Beckenham.
Mice were injected subcutaneously with
2 x 104 tumour cells and 2 days later given
C. parvum, irradiated tumour cells, or both
admixed, into the footpad. Tumour growth
was unaffected by C. parvum or tumour cells
alone, but was suppressed by appropriate
mixtures. The conditions for successful
therapy were: 1. sufficient tumour cells
(> 5 x 104); 2. sufficient, but not excessive,
C. parvum (optimally between about 5 to
20 [kg, increasing with the dose of tumour
cells); 3. the same tumour cells in the tumour
challenge and treatment mixture; other
MCA tumour cells were ineffective; 4. mice
with an intact T cell system; tumour growth
was not suppressed in T cell depleted mice.
The results suggest that the therapeutic
effect depends on the potentiation by C.
parvum of a T cell dependent component of
the immune response to TSTAs.
ROLE OF IMMUNOCOMPETENCE IN
LOCALIZED BCG SUPPRESSION OF
TUMOUR GROWTH. M. V. PIMM and
D. G. Hopper, Cancer Research Campaign
Laboratories, University ofNottingham.
Admixture ofBCG organisms with cells of
syngeneically transplanted rat tumours pre-
vents their development and this leads to
immunologically specific rejection of tumour
deposits at distant sites. Immunosuppres-
sion by whole body irradiation did not pre-
vent suppression ofgrowth from mixed BCG:
tumour cell inocula but did abrogate the
concomitant rejection of distant challenge
inocula. Tumour suppression at the site of
BCG was, however, prevented by macrophage
depletion of the host by silica treatment.
These observations suggest that local BCG
suppression of tumour does not require
lymphocyte mediated immune responses and
probably depends on less specific macrophage
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